Viewing Study NCT04658433



Ignite Creation Date: 2024-05-06 @ 3:30 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04658433
Status: COMPLETED
Last Update Posted: 2022-02-24
First Post: 2020-12-05

Brief Title: The Effect of Omega -3 Supplements on the Serum Levels of ACEACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19 A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People
Sponsor: Applied Science Private University
Organization: Applied Science Private University

Study Overview

Official Title: The Effect of Omega -3 Supplements on the Serum Levels of ACEACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19 A Randomized Clinical Trial in the COVID-19 Uninfected Jordanian People
Status: COMPLETED
Status Verified Date: 2022-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The Renin-Angiotensin-Aldosterone System RAAS is involved in blood pressure regulation and electrolyte balance Angiotensin-converting enzyme ACE is a critical regulator of RAAS by cleaving angiotensin Ang1 to Angiotensin2 Ang2 which is the most powerful biologically active product of RAAS 1 In the same context angiotensin-converting enzyme 2 ACE2 converts Ang2 to Ang 1-7 which is a vasodilator antithrombotic and antihypertrophic peptide 2 ACE2 which is found in many tissues 3 has opposite effects to ACE on the heart kidneys and lungs 4 Many pathological conditions in particular cardiovascular disease CVD have shown a link between a disturbance in ACEACE2 ratio and the downregulation of ACE2 levels 5 Also ACEACE2 has been reported to be higher in moderate to severe chronic heart failure 6 as well as systolic blood pressure 7 Recently an elevated ACEACE2 ratio is linked to Coronavirus disease 2019 COVID-19 SARS-COV2 enters target cells by binding of the spike protein to ACE2 and a specific transmembrane serine protease 2 TMPRSS2 for the spike S protein priming which also leads to downregulation of ACE2 8 Down-regulation of ACE2 caused by Coronavirus may have a potential role in the pathogenesis of COVID-19 infection Accordingly people with a higher ACEACE2 ratio may be more at increased risk of worse Covid-19 consequences 9

On the other hand omega-3 fatty acids could decrease CVD risk by their anti-inflammatory anti-thrombotic function 10 A meta-analysis comprising 15806 patients showed that omega-3 fatty acids associated with a 30 reduction in fatal myocardial infarction and sudden death in addition to a 20 reduction in overall mortality 11 To the best of our knowledge no clinical trials have evaluated the effect of omega-3 supplementation on serum ACEACE2 ratio which is recently ascribed as a potential key in 2019 Covid-19 as well as CVD 59
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None